Lonza Group AG (ETR:LO3)
Germany flag Germany · Delayed Price · Currency is EUR
620.60
-14.40 (-2.27%)
At close: May 7, 2025

Lonza Group AG Company Description

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments.

The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.

Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates.

This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging.

The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies.

This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets.

Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers.

Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Lonza Group AG
Lonza Group AG logo
Country Switzerland
Founded 1897
Industry Other
Employees 18,944
CEO Wolfgang Wienand

Contact Details

Address:
Muenchensteinerstrasse 38
Basel, 4002
Switzerland
Phone 41 61 316 81 11
Website lonza.com

Stock Details

Ticker Symbol LO3
Exchange Deutsche Börse Xetra
Fiscal Year January - December
Reporting Currency CHF
SIC Code 2800

Key Executives

Name Position
Wolfgang Wienand Chief Executive Officer
Philippe Deecke Chief Financial Officer
Maria Nunez Chief Operating Officer
Daniel Buchta Head of Investor Relations